ARID2 and hepatocellular carcinoma: The inhibition of ARID2 expression enhances G1/S transition related to the upregulation of cyclin D1, cyclin E1, and CDK4 and to the phosphorylation of the retinoblastoma protein (Rb) in hepatocellular carcinoma (HCC)46.